RNU1-68P

Across TCGA pan-cancer cohorts, RNU1-68P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated RNU1-68P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU1-68P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU1-68P expression acts as an unfavorable survival marker.

BLCA, KICH, and LIHC are the cancer types where RNU1-68P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.082	0.688	<.001	108	view →
KICH	OS	Tertile	II,III,IV	0.070	0.828	<.001	63	view →
LIHC	OS	Tertile	II,III,IV	0.165	0.719	<.001	36	view →
DLBC	OS	Tertile	All	0.628	0.935	.014	18	view →
LUAD	DFS	Tertile	III,IV	0.206	0.670	.015	18	view →
LUSC	DFS	Tertile	III,IV	0.222	0.638	.018	18	view →
ESCA	OS	Tertile	II,III,IV	0.105	0.867	.016	18	view →
PCPG	DFS	Tertile	All	0.167	0.819	.010	18	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
ACC	DFS	Tertile	All	0.195	0.748	.003	9	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

RNU1-68P–BLCA (OS)

Open the BLCA breakdown →